Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Cognitive Behavioral Therapy in Prolonging the Antidepressant Effects of Intravenous Ketamine


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02289248

Organisation Name: Yale University

Overal Status: Completed

Start Date: February 2015

Last Update: March 1, 2017

Lead Sponsor: Yale University

Brief Summary: Subjects with depressive episodes will be recruited to undergo a brief 2 week course of IV infusions of ketamine in combination with cognitive behavioral therapy for 8 weeks.

Conditions:
  • Depression


Total execution time in seconds: 0.19803285598755